Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

6 results
Display

Genetic predisposition in nonalcoholic fatty liver disease

Sookoian S, Pirola CJ

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease whose prevalence has reached global epidemic proportions. Although the disease is relatively benign in the early stages, when...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The gene expression signature of metabolic dysfunction- associated steatotic liver disease from a multiomics perspective

Pirola CJ, Sookoian S

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Personalized medicine in nonalcoholic fatty liver disease

Pirola CJ, Sookoian S

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait

Pirola CJ, Sookoian S

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Genetics in non-alcoholic fatty liver disease: The role of risk alleles through the lens of immune response

Sookoian S, Pirola CJ

The knowledge on the genetic component of non-alcoholic fatty liver disease (NAFLD) has grown exponentially over the last 10 to 15 years. This review summarizes the current evidence and the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Precision medicine in nonalcoholic fatty liver disease: New therapeutic insights from genetics and systems biology

Sookoian S, Pirola CJ

Despite more than two decades of extensive research focusing on nonalcoholic fatty liver disease (NAFLD), no approved therapy for steatohepatitis—the severe histological form of the disease—presently exists. More importantly, new...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr